Business
Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand
(TheNewswire)   Toronto, Ontario – TheNewswire - January 7, 2026 -- Ventrip...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand\n(TheNewswire)\n\n\n\n \n\n\nToronto, Ontario – TheNewswire - January 7, 2026 -- Ventripoint Diagnostics Ltd. (Ventripoint or the Corporation,\nTSXV:VPT), a leading innovator in AI-powered cardiac imaging\ntechnology, today announced, in response to significant investor\ninterest, it will double its previously announced non-brokered private\nplacement (“Offering”) (See press release December 30,\n2025) from $500,000 to $1,000,000 subject to TSX Venture Exchange\n(“TSXV or the\nExchange”) approval.\n\n\n \n\n\nEach Unit will be comprised of one (1) common share\n(“Common Shares”) of the Corporation, and one (1) common share purchase\nwarrant (“Warrants”). \n\n\n \n\n\nEach whole Warrant will entitle\nthe holder thereof to purchase one (1) Common Share at a price of\n$0.13 for a period of 24 months from the closing of the Offering. The\nCorporation reserves the right to accelerate the Warrant expiry period\nupon 30 days notice, if the Common Shares trade at $0.26 or above on\nthe TSXV for a period of 10 consecutive days, including days where no\ntrades occur.\n\n\n \n\n\nThe Corporation may pay cash finder’s fee and issue\ncommon share purchase warrants (“Finder’s Warrants”) of up to 8% of the gross proceeds of the Offering. Each\nFinder’s Warrant will be exercisable into one Common Share at an\nexercise price of CDN$0.13 per Common Share for a period of 24\nmonths from the closing of the Offering.\n\n\n \n\n\nThe Corporation will use the proceeds of the Offering\nto support critical commercialization\nactivities, manufacturing scale-up, continued regulatory submissions,\nand operational requirements.\n\n\n \n\n\nAll securities issued and issuable pursuant to the\nOffering will be subject to a hold period of four months plus one day\nfrom the date of closing of the Offering. The Offering is subject to\napproval by the Exchange.\n\n\n \n\n\nThe securities offered will not be\nregistered under the U.S. Securities Act of 1933, as amended, and may\nnot be offered or sold in the United States absent a registration\nstatement or an applicable exemption from the registration\nrequirements. The press release shall not constitute ...